Document is current
Any future updates will be listed below
-
Authors
Okoro, Roland Nnaemeka http://orcid.org/0000-0002-6391-5000
Geidam, Ado Danazumi
Bukar, Audu Abdullahi
Zarami, Abba Bukar
Ohieku, John David
Musa, Alhaji Bukar
Yerima, Timothy Samuel
-
Clinical Trials BETA
Clinical trials referenced in this document:
pactr202002644579177 at Pan African Clinical Trial RegistryDocuments that mention this clinical trial
Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy
https://doi.org/10.1186/s43094-023-00460-w
-
Funding
Funding for this research was provided by:
Royal Society of Tropical Medicine and Hygiene
- License Information
-
More Information
Article History
Received: 6 August 2022
Accepted: 25 January 2023
First Online: 31 January 2023
Declarations
:
: All participants provided written informed consent voluntarily. The trial was approved by the Health Research Ethics Committee of the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria (UMTH/REC/555). Trial Registration: This study is registered at ExternalRef removed (The Pan African Clinical Trials Registry Identifier: PACTR202002644579177). All the authors vouch for the completeness and accuracy of the data and analyses presented and for the fidelity of the trial to the protocol.
: All the authors approved the manuscript for publication. Also, the participants gave consent for the publication of this manuscript.
: The authors declare that they have no competing interests.
